Web Results

Mecasermin - Wikipedia

en.wikipedia.org/wiki/Mecasermin

Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in ...

Mecasermin: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/mecasermin.html

Jan 6, 2017 ... Easy to read patient leaflet for mecasermin. Includes indications, proper use, special instructions, precautions, and possible side effects.

Mecasermin - DrugBank

www.drugbank.ca/drugs/DB01277

May 16, 2007 ... Description, Mecasermin contains recombinant-DNA-engineered human insulin- like growth factor-1 (rhIGF-1). IGF-1 consists of 70 amino acids ...

Increlex

www.increlex.com/

Manufacturer's information about recombinant human insulin-like growth factor-1, marketed under the brand name Increlex (generic name mecasermin).

Increlex (mecasermin) - CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/884/increlex-mecasermin/

Listing for FDA approved drug therapies archives from CenterWatch. ( mecasermin)

Increlex - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2014/021839s016lbl.pdf

INCRELEX® (mecasermin [rDNA origin] injection) number of cases indicative of anaphylaxis requiring hospitalization have been reported. Parents and patients ...

Insulin-Like Growth Factor-1 (IGF-1) Analogues: Mecasermin ... - Aetna

www.aetna.com/cpb/medical/data/700_799/0711.html

Number: 0711. Policy. Aetna considers mecasermin (Increlex) and mecasermin rinfabate (Iplex)* medically necessary for the treatment of growth failure in ...

Increlex®, mecasermin - OmedaRx

www.omedarx.com/files/Increlex, mecasermin dru126.pdf

Policy No: dru126. Topic: Increlex®, mecasermin. Date of Origin: January 3, 2006 . Committee Approval Date: January 8, 2016. Next Review Date: January 2017.

INCRELEX, INN: mecasermin - European Medicines Agency

www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000704/WC500032222.pdf

INCRELEX (mecasermin) is recombinant human insulin-like growth factor-1 ... Mecasermin was granted orphan status in the EU for “Treatment of growth ...